Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06935253 · ClinicalTrials.gov registry record · NA
Large Language Models To Improve the Quality of Care of Cardiology Patients
A NA study of Genetic Disease and Cardiomyopathy, sponsored by Stanford University.
- Recruiting
- Registry status
- NA
- Development phase
- 12
- Enrollment target
- 1
- Study location
NCT06935253 is a NA study of Genetic Disease and Cardiomyopathy that is actively recruiting participants, run by Stanford University. The registered enrollment target is 12 participants, below the 2,561-participant average among 30 other Genetic Disease trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06935253, a NA study of Genetic Disease and Cardiomyopathy, is actively recruiting participants, sponsored by Stanford University.
- RECRUITING
- Registry status
- NA
- Development phase
- 12 participants
- Enrollment target
- 1
- Study location
Study Summary
This study evaluates the impact of large language models (LLMs) versus traditional decision support tools on clinical decision-making in cardiology. General cardiologists will be randomized to manage real patient cases from a cardiovascular genetic cardiomyopathy clinic, with or without AI assistance. Each case will be assessed by two cardiologists, and their responses will be graded by blinded subspecialty experts using a standardized evaluation rubric.
Conditions Studied
Interventions
- OTHER Large Language Model
Study Locations (1)
California
- Stanford - Palo Alto
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2025-01-10 |
| Est. Completion | 2025-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06935253
The ClinicalTrials.gov registry entry for NCT06935253 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,561-participant average among 30 other Genetic Disease trials with a reported enrollment target (100% lower). The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with Genetic Disease appearing as the primary indexed condition, and to 1 intervention - of which Large Language Model is the first listed.
NCT06935253 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT06935253 about?
NCT06935253 is a clinical study titled "Large Language Models To Improve the Quality of Care of Cardiology Patients". This study evaluates the impact of large language models (LLMs) versus traditional decision support tools on clinical decision-making in cardiology. General cardiologists will be randomized to manage real patient cases from a cardiovascular genetic cardiomyopathy clinic, with or without AI assistanc...
What is the current status of trial NCT06935253?
This trial is currently recruiting. It is a NA study. The enrollment target is 12 participants. The study started on 2025-01-10. Estimated completion is 2025-12.
What conditions does trial NCT06935253 study?
This clinical trial studies the following conditions: Genetic Disease, Cardiomyopathy, Hypertrophic Cardiomyopathy (HCM), Cardiology.
What interventions are being tested in trial NCT06935253?
The interventions under investigation include: Large Language Model (OTHER).
Who is sponsoring clinical trial NCT06935253?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06935253 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Genetic Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
An Adaptive Clinical Trial of BeginNGS Newborn Screening for Hundreds of Genetic Diseases by Genome Sequencing
RECRUITING · NA
-
Grand Valley State University (GVSU) Skills on Wheels
ACTIVE NOT RECRUITING · NA
-
Clinical Decision Support to Identify Pediatric Patients With Undiagnosed Genetic Disease
ACTIVE NOT RECRUITING · NA
-
Overcoming Barriers to Accessing Genetic Medicine
ACTIVE NOT RECRUITING · NA
-
Pediatric Powered Wheelchair Standing Devices: An Exploratory Study
ACTIVE NOT RECRUITING · NA
-
The Electronic Medical Records and GEnomics (eMERGE) Network Genomic Risk Assessment
ACTIVE NOT RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.